1. Basil, B., Jordan, R., Loveless, A., and Max-well, D.R.: Pharmacological properties of M & B 17,803 A, a cardioselective ?-adrenoceptor blocking agent. J. Pharmacol. (Paris)2 195?197 (1971)
2. Biron P., Proulx, A., Lapointe, L., Tremblay, G., and Nadeau, R.: Intravenous acebutolol (M & B 17,803 A, Poulenc) in 20 selected cases of cardiac arrhythmia. Clin. Res.21 1015 (1973)
3. Biron, P., Tremblay, G., Nadeau, R., Proulx, A., Lapointe, L.: Antiarrhythmic properties of a new beta blocker, acebutolol (M & B 17,803 A). Clin. Pharmacol. Ther.15 200 (1974)
4. Coleman, A.J., and Leary, W.P.: Cardiovascular effects of acebutolol (M & B 17,803 A) in exercising man; a comparative study with practolol and propranolol. Curr. ther. Res.14 673?678 (1972)
5. Cuthbert, M.F., and Owusu-Ankomah, K.: Effect of M & B 17,803 A, a new ?-adrenoceptor blocking agent, on the cardiovascular response to tilting and to isoprenaline in man. Brit. J. Pharmacol.43 639?648 (1971)